NEW PHARMACEUTICAL COMPOSITION WHICH HAS SUSTAINED RELEASE PROFILES

PURPOSE: A novel pharmaceutical composition with constant release is provided to continuously release drug without affect to the gastrointestinal condition. CONSTITUTION: A novel pharmaceutical composition contains 25-300mg of levosulpiride and soluble polymers or insoluble polymers. The soluble pol...

Full description

Saved in:
Bibliographic Details
Main Authors CHOI, JAE SEUNG, NAM, KYOUNG TAE
Format Patent
LanguageEnglish
Korean
Published 10.08.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:PURPOSE: A novel pharmaceutical composition with constant release is provided to continuously release drug without affect to the gastrointestinal condition. CONSTITUTION: A novel pharmaceutical composition contains 25-300mg of levosulpiride and soluble polymers or insoluble polymers. The soluble polymers contain one or more of hydroxypropylene cellulose, polyethylene oxide, carbomer, hydroxypropylcellulose, hydroxyethyl cellulose, xanthan gum, and Arabia rubber. The pharmaceutical composition also contains 2-60 weight% of pH adjusting agent. The pH adjusting agent includes furmaric acid, citric acid, maleic acid, tartaric acid, alginic acid, maleic acid, succinic acid, boric acid, or pharmaceutically acceptable pH adjusting agent.
Bibliography:Application Number: KR20100009751